| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |